Skip to main content
NCBI home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2005 Jun;81(3):267–270. doi: 10.1136/sti.2004.011619

Health related quality of life in genital herpes: a pilot comparison of measures

D Fisman 1
PMCID: PMC1744978  PMID: 15923300

Abstract

Methods: We provided self administered interviews to 39 individuals with recurrent GH recruited from an STD clinic and a GH support group in southern Ontario, Canada. Health preference estimates were generated using visual analogue scales (VAS), a time-tradeoff approach (TTO) and the Health Utilities Index Mark-II (HUI-II). Quality of life was also assessed with the Recurrent Genital Herpes Quality of Life scale (RGHQoL).

Results: Average (SD) health values for asymptomatic and symptomatic genital herpes were 0.89 (0.21) and 0.89 (0.22) using TTO, and 0.76 (0.30) and 0.71 (0.30) using VAS. Health utility estimates generated with HUI-II for transient symptomatic and asymptomatic health states were 0.93 (0.08) and 0.80 (0.16). Log transformed health value estimates exhibited convergent validity when compared to RGHQoL, as did health utility estimates for symptomatic GH. Utility scores for symptomatic GH increased (improved) with increasing age; no other subject characteristic was predictive of preference weights.

Conclusions: Preference based measures of health related quality of life can be elicited with relative ease in the context of genital herpes, and preference weights are correlated with quality of life scores generated using the RGHQoL. Generation of preference weights will permit direct comparison of the economic attractiveness of herpes prevention interventions with that of other commonly available health interventions.

Full Text

The Full Text of this article is available as a PDF (70.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bayoumi A. M., Redelmeier D. A. Economic methods for measuring the quality of life associated with HIV infection. Qual Life Res. 1999 Sep;8(6):471–480. doi: 10.1023/a:1008969512182. [DOI] [PubMed] [Google Scholar]
  2. Brazier John, Roberts Jennifer, Deverill Mark. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 Mar;21(2):271–292. doi: 10.1016/s0167-6296(01)00130-8. [DOI] [PubMed] [Google Scholar]
  3. Carney O., Ross E., Bunker C., Ikkos G., Mindel A. A prospective study of the psychological impact on patients with a first episode of genital herpes. Genitourin Med. 1994 Feb;70(1):40–45. doi: 10.1136/sti.70.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carney O., Ross E., Ikkos G., Mindel A. The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes. Genitourin Med. 1993 Dec;69(6):457–459. doi: 10.1136/sti.69.6.457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Corey Lawrence, Wald Anna, Patel Raj, Sacks Stephen L., Tyring Stephen K., Warren Terri, Douglas John M., Jr, Paavonen Jorma, Morrow R. Ashley, Beutner Karl R. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med. 2004 Jan 1;350(1):11–20. doi: 10.1056/NEJMoa035144. [DOI] [PubMed] [Google Scholar]
  6. Doward L. C., McKenna S. P., Kohlmann T., Niero M., Patrick D., Spencer B., Thorsen H. The international development of the RGHQoL: a quality of life measure for recurrent genital herpes. Qual Life Res. 1998 Feb;7(2):143–153. doi: 10.1023/a:1008857426633. [DOI] [PubMed] [Google Scholar]
  7. Fisman D. N., Hook E. W., 3rd, Goldie S. J. Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2. Sex Transm Infect. 2003 Feb;79(1):45–52. doi: 10.1136/sti.79.1.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Fisman David N., Lipsitch Marc, Hook Edward W., 3rd, Goldie Sue J. Projection of the future dimensions and costs of the genital herpes simplex type 2 epidemic in the United States. Sex Transm Dis. 2002 Oct;29(10):608–622. doi: 10.1097/00007435-200210000-00008. [DOI] [PubMed] [Google Scholar]
  9. Fleming D. T., McQuillan G. M., Johnson R. E., Nahmias A. J., Aral S. O., Lee F. K., St Louis M. E. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997 Oct 16;337(16):1105–1111. doi: 10.1056/NEJM199710163371601. [DOI] [PubMed] [Google Scholar]
  10. Krahn M., Gafni A. Discounting in the economic evaluation of health care interventions. Med Care. 1993 May;31(5):403–418. doi: 10.1097/00005650-199305000-00003. [DOI] [PubMed] [Google Scholar]
  11. Laupacis A., Feeny D., Detsky A. S., Tugwell P. X. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations. CMAJ. 1992 Feb 15;146(4):473–481. [PMC free article] [PubMed] [Google Scholar]
  12. Lenert L., Kaplan R. M. Validity and interpretation of preference-based measures of health-related quality of life. Med Care. 2000 Sep;38(9 Suppl):II138–II150. doi: 10.1097/00005650-200009002-00021. [DOI] [PubMed] [Google Scholar]
  13. Nease R. F., Jr Challenges in the validation of preference-based measures of health-related quality of life. Med Care. 2000 Sep;38(9 Suppl):II155–II159. doi: 10.1097/00005650-200009002-00023. [DOI] [PubMed] [Google Scholar]
  14. Neumann P. J., Goldie S. J., Weinstein M. C. Preference-based measures in economic evaluation in health care. Annu Rev Public Health. 2000;21:587–611. doi: 10.1146/annurev.publhealth.21.1.587. [DOI] [PubMed] [Google Scholar]
  15. Patel R., Tyring S., Strand A., Price M. J., Grant D. M. Impact of suppressive antiviral therapy on the health related quality of life of patients with recurrent genital herpes infection. Sex Transm Infect. 1999 Dec;75(6):398–402. doi: 10.1136/sti.75.6.398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Roberts Craig M., Pfister John R., Spear Scott J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex Transm Dis. 2003 Oct;30(10):797–800. doi: 10.1097/01.OLQ.0000092387.58746.C7. [DOI] [PubMed] [Google Scholar]
  17. Scoular A. Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision. Sex Transm Infect. 2002 Jun;78(3):160–165. doi: 10.1136/sti.78.3.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stanberry Lawrence R., Spruance Spotswood L., Cunningham Anthony L., Bernstein David I., Mindel Adrian, Sacks Stephen, Tyring Stephen, Aoki Fred Y., Slaoui Moncef, Denis Martine. Glycoprotein-D-adjuvant vaccine to prevent genital herpes. N Engl J Med. 2002 Nov 21;347(21):1652–1661. doi: 10.1056/NEJMoa011915. [DOI] [PubMed] [Google Scholar]
  19. Tengs T. O., Adams M. E., Pliskin J. S., Safran D. G., Siegel J. E., Weinstein M. C., Graham J. D. Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal. 1995 Jun;15(3):369–390. doi: 10.1111/j.1539-6924.1995.tb00330.x. [DOI] [PubMed] [Google Scholar]
  20. Torrance G. W., Feeny D. H., Furlong W. J., Barr R. D., Zhang Y., Wang Q. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. Med Care. 1996 Jul;34(7):702–722. doi: 10.1097/00005650-199607000-00004. [DOI] [PubMed] [Google Scholar]
  21. Torrance G. W., Feeny D., Furlong W. Visual analog scales: do they have a role in the measurement of preferences for health states? Med Decis Making. 2001 Jul-Aug;21(4):329–334. doi: 10.1177/0272989X0102100408. [DOI] [PubMed] [Google Scholar]
  22. Tsevat J., Sherman S. N., McElwee J. A., Mandell K. L., Simbartl L. A., Sonnenberg F. A., Fowler F. J., Jr The will to live among HIV-infected patients. Ann Intern Med. 1999 Aug 3;131(3):194–198. doi: 10.7326/0003-4819-131-3-199908030-00006. [DOI] [PubMed] [Google Scholar]
  23. Wald A., Langenberg A. G., Link K., Izu A. E., Ashley R., Warren T., Tyring S., Douglas J. M., Jr, Corey L. Effect of condoms on reducing the transmission of herpes simplex virus type 2 from men to women. JAMA. 2001 Jun 27;285(24):3100–3106. doi: 10.1001/jama.285.24.3100. [DOI] [PubMed] [Google Scholar]
  24. Weinstein M. C., Siegel J. E., Gold M. R., Kamlet M. S., Russell L. B. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA. 1996 Oct 16;276(15):1253–1258. [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES